Supplements · Metabolic & Cardiometabolic
metformin causes vitamin B12 deficiency
In plain terms: Does metformin cause vitamin B12 deficiency?
Part of: 💊 metformin
Yes — long-term metformin lowers serum B12 and raises risk of biochemical deficiency in a dose- and duration-dependent way, confirmed by both the DPPOS and a placebo-controlled RCT plus meta-analyses; clinically overt deficiency is less common but real.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (10)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Chapman 2016 · Diabetes Metab | meta-analysis | supports | moderate | Meta-analysis: metformin associated with reduced serum B12, with dose and duration as risk modifiers. |
| Khan 2022 · Cureus | observational | supports | low | Cross-sectional/cohort: higher B12 deficiency prevalence and peripheral neuropathy in metformin-treated T2D; smaller, lower-quality but concordant. |
| Out 2018 · Diabetes Obes Metab | RCT | tested-null | moderate | HOME negative control: metformin did NOT lower vitamin D (no effect), showing the B12 finding is specific rather than a generic nutrient artifact. |
| Out 2018 · J Diabetes Complications | RCT | supports | moderate | HOME post-hoc: metformin raised methylmalonic acid (functional B12 marker), confirming the deficiency is metabolically real, not just a transport artifact. |
| Liu 2015 · Intern Emerg Med | meta-analysis | supports | moderate | Meta-analysis: metformin use significantly associated with lower B12 and higher deficiency risk in T2D across studies. |
| Prescrire 2014 · Prescrire Int | meta-analysis | supports | moderate | Review notes metformin sometimes causes B12 deficiency leading to macrocytic anemia or peripheral neuropathy. |
| Aroda 2016 · J Clin Endocrinol Metab | RCT | supports | high | DPPOS: long-term metformin increased risk of B12 deficiency vs placebo (HR rising with duration), with anemia and neuropathy signals; landmark prevention-cohort confirmation. |
| de Jager 2010 · BMJ | RCT | supports | high | HOME placebo-controlled RCT (4.3y): metformin lowered B12 by ~19% and raised risk of B12 deficiency (OR ~3), establishing causality not just association. |
| Out 2019 · J Diabetes | RCT | supports | moderate | HOME-trial analysis: metformin associated with lower B12, more deficiency, and links to anemia and peripheral neuropathy; reinforces clinical sequelae. |
| Rubbani 2025 · Cureus | meta-analysis | mixed | low | Meta-analysis links long-term metformin to iron-deficiency anemia and oxidative stress, noting associated B12 depletion. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.